Key Clinical Message Patients with common variable immunodeficiency are prone to infections, and this poses a particular challenge during pregnancy, when the requirement for immunoglobulin (Ig) replacement therapy is even more demanding so as to achieve an effective protection also of the fetus. This case report highlights the benefits observed with subcutaneous IgG self-administration in the management of common variable immunodeficiency (CVID) during pregnancy, in terms of efficacy and safety
Management of common variable immunodeficiency by subcutaneous IgG self-administration during pregnancy - a case report
MARASCO, CAROLINA;VENTURELLI, ALBERTA;RAO, LUIGIA;VACCA, Angelo;CARRATU', Maria Rosaria
2017-01-01
Abstract
Key Clinical Message Patients with common variable immunodeficiency are prone to infections, and this poses a particular challenge during pregnancy, when the requirement for immunoglobulin (Ig) replacement therapy is even more demanding so as to achieve an effective protection also of the fetus. This case report highlights the benefits observed with subcutaneous IgG self-administration in the management of common variable immunodeficiency (CVID) during pregnancy, in terms of efficacy and safetyFile in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Marasco_et_al-2017-Clinical_Case_Reports.pdf
accesso aperto
Descrizione: case report
Tipologia:
Documento in Versione Editoriale
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
120.63 kB
Formato
Adobe PDF
|
120.63 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
